Evidence map›Paper›PMID 41926712›Full record

ArticleJournal of the American Chemical Society2026

Machine Learning Optimization of Laser Ablation in Liquid for the Green and Low-Cost Synthesis of Clean Gold Nanoparticles.

Runpeng Miao, Catherine Reffatto, Mattia Cattelan, Rafael Torres-Mendieta, Luca Menilli, Vincenzo Amendola

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Runpeng MiaoDepartment of Chemical Sciences, University of Padova, via Marzolo 1, Padova I-35131, Italy.
Catherine ReffattoDepartment of Chemical Sciences, University of Padova, via Marzolo 1, Padova I-35131, Italy.
Mattia CattelanDepartment of Chemical Sciences, University of Padova, via Marzolo 1, Padova I-35131, Italy.ORCID 0000-0001-9314-1475
Rafael Torres-MendietaDepartment of Chemical Sciences, University of Padova, via Marzolo 1, Padova I-35131, Italy.
Luca MenilliDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, via Marzolo 5, Padova I-35131, Italy.
Vincenzo AmendolaDepartment of Chemical Sciences, University of Padova, via Marzolo 1, Padova I-35131, Italy.ORCID 0000-0002-9937-7005

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While gold nanoparticles (Au NPs) are widely employed in modern technology, their large-scale synthesis still faces challenges related to cost and sustainability. In addition, chemical contaminants are a problem when the highest purity is demanded, such as for biomedicine, catalysis, and several processes mediated by the NP surface. Laser ablation in liquid (LAL) is a promising technique for producing surface-clean Au NPs, although its scalability has not yet matched that of conventional chemical methods. In this work, the LAL synthesis of 5 nm Au NPs in a batch configuration was optimized using machine learning. A 3.4-fold increase in investment-specific productivity was achieved compared to the previous LAL record, and at 1/18 of the initial investment. This makes the laser synthesis of Au NPs "greener" and four times cheaper than gram-scale chemical synthesis via the classical Turkevich-Frens method. Besides, the chemical-free and surface-clean Au NPs showed better cytocompatibility, superior performance as MALDI substrates, higher catalytic activity in the reduction of nitrothiophenol, higher surface thiol coverage, and a more intense plasmon absorption compared to that of the commercial counterpart. This study highlights the positive prospects of machine learning-optimized LAL for the low-cost and environmentally sustainable production of metal NPs possessing convenient properties not achievable through wet-chemistry routes.

Identifiers

PMID41926712
PMCPMC13088233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.